US 6,274,599 B1Granted

Cisapride extended release

AssigneeJanssen Pharmaceutica NV

InventorsEugene Marie Jozef Jans, Paul Marie Victor Gilis

Life of this patent

Estimating the term…

Abstract

The present invention concerns extended release formulations comprising cisapride-(L)-tartrate, in particular an oral formulation, the use thereof as a medicine, especially in treating gastrokinetic disorders.

Claims7

Dependent claims

An extended release formulation comprising cisapride-(L)-tartrate and a mixture of hydroxypropylmethyl cellulose and another viscous polymer, suitable for oral administration.

Dependencies are inferred from the claim text.

Facts

Application: 09/419,590Filed 18 Oct 1999 · division
Priority: EP 942031842 Nov 1994
Granted: 14 Aug 2001
Term ends: Not estimatedThe source records don’t support an estimate.

Classification7 codes

A61K 31/4468
Non condensed piperidines, e.g. piperocaine: having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
A61K 9/2054
Polysaccharides, e.g. alginate, gums; Cyclodextrin: cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
A61P 1/00
Drugs for disorders of the alimentary tract or the digestive system
A61P 1/08
Drugs for disorders of the alimentary tract or the digestive system: for nausea, cinetosis or vertigo; Antiemetics

Family

PCT/EP95/04198Parent of this continuation · filed 25 Oct 1995
Application08/817,739Parent of this division · filed 23 Apr 1997
US 6,153,623 AParent of this division
Application08/817,739Parent of this continuation
US 6,274,599 B1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results